---

OTOGENIC BRAIN ABSCESS

A Complication of Chronic Suppurative Otitis Media (CSOM)

---

1. DEFINITION

---

2. INCIDENCE & EPIDEMIOLOGY

---

3. AETIOLOGY — PREDISPOSING CONDITIONS

• CSOM — Unsafe type (Atticoantral/Cholesteatoma) — Most common
• CSOM — Safe type (Tubotympanic) — Less common
• Acute Otitis Media with coalescent mastoiditis
• Petrositis (Gradenigo's syndrome)
• Labyrinthitis (suppurative)
• Post-traumatic (temporal bone fracture)
• Post-surgical (iatrogenic)

---

4. BACTERIOLOGY

---

5. ROUTES OF SPREAD (PATHWAYS)

╔══════════════════════════════════════════════════════════╗
║         ROUTES OF SPREAD — OTOGENIC BRAIN ABSCESS       ║
╠══════════════════════════════════════════════════════════╣
║                                                          ║
║  1. DIRECT EXTENSION (Most Common)                       ║
║     Middle ear/Mastoid                                   ║
║         ↓ (erosion of tegmen tympani/tegmen antri)       ║
║     Extradural → Subdural → Temporal lobe abscess        ║
║                                                          ║
║  2. VIA LABYRINTH                                        ║
║     Suppurative labyrinthitis                            ║
║         ↓ (through internal auditory canal)              ║
║     Cerebellar abscess                                   ║
║                                                          ║
║  3. PERIVASCULAR / PERINEURAL (Thrombophlebitis)         ║
║     Sigmoid sinus thrombophlebitis                       ║
║         ↓ (retrograde venous spread)                     ║
║     Cerebellar abscess                                   ║
║                                                          ║
║  4. HAEMATOGENOUS (Bacteraemia)                          ║
║     Blood-borne spread (rare in otogenic)                ║
║         ↓                                                ║
║     Any lobe (usually frontal)                           ║
║                                                          ║
╚══════════════════════════════════════════════════════════╝

---

6. SITES OF ABSCESS

---

7. STAGES OF ABSCESS FORMATION

Stage 1: EARLY CEREBRITIS (Days 1–3)
    ↓ Perivascular infiltration of inflammatory cells
    ↓ Central coagulative necrosis
    ↓ Marked surrounding oedema

Stage 2: LATE CEREBRITIS (Days 4–9)
    ↓ Pus formation → enlarging necrotic centre
    ↓ Macrophage & fibroblast infiltration
    ↓ Thin fibroblastic capsule begins to form

Stage 3: EARLY CAPSULE (Days 10–13)
    ↓ Well-formed reticular/collagen capsule
    ↓ Neovascularisation of capsule wall
    ↓ Surrounding oedema decreases slightly

Stage 4: LATE CAPSULE (Day 14 onwards)
    ↓ Thick fibrous capsule — "ring enhancing" on imaging
    ↓ Central liquefactive necrosis (pus)
    ↓ Daughter abscess formation possible

---

8. CLINICAL FEATURES

Pathognomonic Triad (Classic — present in <50% of cases):

Headache + Fever + Focal Neurological Deficit (Harrison's, 21st Ed., p. 4203)

Four Clinical Stages:

• Headache, mild pyrexia, malaise
• Meningeal irritation signs
• Duration: few days
• Often missed / attributed to underlying ear disease

• Headache settles, patient appears better
• MOST DANGEROUS STAGE — false sense of security
• Abscess is actually forming and expanding
• Duration: days to weeks

• Raised Intracranial Pressure (ICP):
  • Severe, progressive headache (>75% of patients)
  • Vomiting (projectile)
  • Papilloedema (late sign)
  • Bradycardia + hypertension (Cushing's reflex)
• Focal Neurological Signs:
  • Temporal lobe abscess: Contralateral hemiparesis, aphasia (dominant hemisphere), upper quadrantanopia, dyslexia
  • Cerebellar abscess: Ipsilateral cerebellar signs — DANISH (Dysdiadochokinesia, Ataxia, Nystagmus, Intention tremor, Slurred speech, Hypotonia), past-pointing, broad-based gait
• Seizures (15–35% of patients)
• Fever in only ~50% at time of diagnosis

• Herniation syndromes
• Tentorial herniation → bilateral fixed dilated pupils, decerebrate posturing
• Tonsillar herniation → cardiorespiratory arrest
• Rupture into ventricle → ventriculitis (extremely fatal — >80% mortality)

---

9. DIAGNOSIS

A. Clinical Assessment

• H/O discharging ear (CSOM) — may have stopped recently (dangerous)
• Neurological examination
• Fundoscopy (papilloedema)

B. Laboratory Investigations

C. Imaging — KEY

Satellite (Daughter) abscesses visible as multiple ring-enhancing lesions

• T1: Hypointense centre (pus), ring isointense capsule
• T2: Hyperintense centre, hyperintense surrounding oedema
• T1 + Gadolinium: Ring enhancement (characteristic)
• DWI (Diffusion Weighted Imaging): Restricted diffusion (bright/hyperintense) in centre — PATHOGNOMONIC of pyogenic abscess; distinguishes from tumour/metastasis
• MR Spectroscopy: Amino acid peaks (valine, leucine, isoleucine), succinate, acetate, lactate peaks confirm pyogenic abscess

• Pure Tone Audiometry: Conductive hearing loss (CHL) or mixed loss
• Tympanometry: Type B (flat) curve
• HRCT Temporal bone: Demonstrates cholesteatoma, tegmen erosion, labyrinthine fistula

• Aspiration material — essential for targeted antibiotic therapy
• Anaerobic culture mandatory

---

10. DIFFERENTIAL DIAGNOSIS

---

11. MANAGEMENT

FLOWCHART — MANAGEMENT OF OTOGENIC BRAIN ABSCESS

┌─────────────────────────────────────────────────────────┐
│         SUSPECTED OTOGENIC BRAIN ABSCESS                │
└──────────────────────┬──────────────────────────────────┘
                       ↓
       ┌───────────────────────────────┐
       │  RESUSCITATION & STABILISE    │
       │  • Airway, Breathing, Circulation│
       │  • IV access, O₂             │
       │  • GCS assessment            │
       └──────────────┬────────────────┘
                      ↓
       ┌───────────────────────────────┐
       │  IMAGING (CT Brain contrast)  │
       │  ± MRI Brain with DWI        │
       └──────────────┬────────────────┘
                      ↓
         ┌────────────┴────────────┐
         ↓                         ↓
  CEREBRITIS STAGE           CAPSULE STAGE
  (No pus collection)      (Pus collection)
         ↓                         ↓
  MEDICAL MANAGEMENT        SURGICAL + MEDICAL
  IV Antibiotics            (see below)
  Anti-oedema measures
  Close monitoring

---

A. MEDICAL MANAGEMENT

• Dexamethasone IV 4–8 mg every 6 hours (controversy — reduces oedema but also antibiotic penetration and capsule formation; use judiciously)
• Mannitol 20% solution — 1–2 g/kg IV over 20–30 min (osmotic diuretic)
• Hyperventilation (PCO₂ target 30–35 mmHg) in ventilated patients
• Head elevation to 30°
• Strict fluid balance

• Phenytoin or Levetiracetam — prophylactic in all patients with brain abscess
• Mandatory for at least 3 months post-surgery

• Duration: Minimum 6–8 weeks total (4 weeks IV, followed by 4 weeks oral)
• Guided by pus culture & sensitivity

---

B. SURGICAL MANAGEMENT

SURGICAL MANAGEMENT
        ↓
┌───────────────────┐        ┌────────────────────────┐
│ BRAIN ABSCESS     │        │ EAR/MASTOID DISEASE    │
│ (Neurosurgery)    │        │ (ENT Surgery)          │
└────────┬──────────┘        └───────────┬────────────┘
         ↓                               ↓
  Options:                     Mastoidectomy
  1. Aspiration (preferred)    (Cortical or Modified
  2. Excision                   Radical/Radical)
  3. Drainage                  to eliminate focus

I. NEUROSURGICAL OPTIONS FOR BRAIN ABSCESS:

• Minimally invasive, safe, repeatable
• Can be performed under local anaesthesia
• Send aspirate for microscopy, C&S, TB, fungi
• Preferred for deep/eloquent area abscesses
• Failure rate: ~15–20% (may need repeat aspiration)

• Indications:
  • Multiloculated abscess
  • Failed aspiration (>3 attempts)
  • Abscess with foreign body (trauma, fungal)
  • Fungal abscess
  • Traumatic abscess
  • Posterior fossa abscess (cerebellar — PREFERRED excision over aspiration)
  • Abscess size >2.5 cm not responding to aspiration
• Posterior fossa approach for cerebellar abscess — suboccipital craniotomy

• Burr hole + drainage with or without drain placement
• Used for large, single, superficial abscesses

II. ENT SURGICAL MANAGEMENT:

• Cortical Mastoidectomy (Simple): For acute coalescent mastoiditis without cholesteatoma
• Modified Radical Mastoidectomy (MRM): For CSOM unsafe type — most commonly performed in otogenic brain abscess — removes cholesteatoma and ensures clearance
• Radical Mastoidectomy: When middle ear is completely destroyed
• Timing: Traditionally staged (brain abscess first, then ear surgery); modern approach — simultaneous surgery by neurosurgery + ENT team

---

COMPREHENSIVE MANAGEMENT ALGORITHM

OTOGENIC BRAIN ABSCESS — MANAGEMENT FLOWCHART
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Patient with CSOM + Neurological symptoms
                 ↓
Emergency CT Brain (contrast) + HRCT Temporal bone
                 ↓
         ┌───────┴───────┐
    Cerebritis           Abscess
    Stage               (capsule)
         ↓                   ↓
   IV Antibiotics      Assess: Size, Location,
   Anti-oedema         GCS, Raised ICP
   Conservative             ↓
   Monitor 24–48h    ┌──────┴───────┐
         ↓          <2.5cm &      >2.5cm or
   If no progress → Accessible  Deteriorating
   Consider surgery       ↓           ↓
                  Aspiration     Excision
                  (Stereotactic)  (Craniotomy)
                         ↓
                Culture-guided IV Antibiotics
                Min 6–8 weeks total
                         ↓
                Repeat CT Brain at
                2–3 weeks (monitor)
                         ↓
              Resolution confirmed on CT?
              ┌──────────┴──────────┐
             YES                    NO
              ↓                     ↓
        ENT Surgery:           Re-aspiration or
        Mastoidectomy          Change antibiotics
        (MRM/Radical)          Consider excision
              ↓
        Audiological rehabilitation
        (Hearing aid / Myringoplasty)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

---

12. COMPLICATIONS OF BRAIN ABSCESS

COMPLICATIONS
├── Rupture into ventricle (Ventriculitis) — MOST FATAL, mortality >80%
├── Meningitis (secondary)
├── Subdural empyema
├── Cerebral herniation (transtentorial / tonsillar)
├── Septicaemia / Septic shock
├── Cerebral infarction (vasospasm)
├── Multiple (daughter) satellite abscesses
├── Persistent neurological deficit
├── Post-operative: wound infection, CSF leak, pneumocephalus
└── Late epilepsy (20–30% long-term)

---

13. PROGNOSIS & OUTCOME FACTORS

---

14. FEATURES DISTINGUISHING TEMPORAL LOBE vs CEREBELLAR ABSCESS

---

15. RECENT ADVANCES (Important for RGUHS)

A. Diagnostic Advances

1. DWI-MRI (Diffusion Weighted Imaging): Now standard — restricted diffusion (bright DWI + dark ADC) distinguishes pyogenic abscess from cystic tumour/metastasis with ~95% sensitivity
2. MR Spectroscopy: Amino acid peaks (valine, leucine, isoleucine) + acetate/succinate peaks confirm pyogenic abscess; lactate/lipid peaks suggest tumour necrosis
3. Neuronavigation-guided stereotactic aspiration: Real-time intraoperative GPS-like tracking for precision aspiration of deep-seated or eloquent area abscesses
4. Metagenomic Next-Generation Sequencing (mNGS) of abscess pus: Identifies unculturable organisms (fungi, rare bacteria, viruses) rapidly — useful in culture-negative cases
5. Endoscopy-assisted mastoidectomy: Reduces surgical morbidity in primary source control

B. Medical Advances

1. Daptomycin + Rifampicin — for MRSA otogenic abscess (superior biofilm penetration)
2. Linezolid — excellent CNS penetration; alternative for MRSA/VRE abscesses
3. Prolonged oral step-down therapy — 4 weeks IV → 4 weeks high-dose oral amoxicillin-clavulanate (controversial but gaining acceptance — IDSA 2024 guidelines)
4. Voriconazole — antifungal of choice for Aspergillus brain abscess (immunocompromised patients)

C. Surgical Advances

1. Robotic-assisted neurosurgery — for deep-seated abscesses (research phase)
2. Endoscope-assisted craniotomy — for posterior fossa cerebellar abscesses
3. Simultaneous ENT + Neurosurgery approach — single-stage surgery (mastoidectomy + abscess drainage simultaneously) — reduces total anaesthesia exposure; reduces time to source control; becoming standard of care in high-volume centres
4. Ommaya reservoir placement — for recurrent/refractory deep abscesses (allows repeated aspiration without repeat craniotomy)

D. Novel Therapies (Under Research)

• Bacteriophage therapy — for multidrug-resistant Pseudomonas/Klebsiella brain abscesses
• Nanoparticle-encapsulated antibiotics — enhanced blood-brain barrier penetration
• Anti-biofilm agents (N-acetylcysteine, dispersin B) as adjuncts to antibiotics

---

16. SUMMARY — QUICK REVISION TABLE

---

17. CLASSIFICATION OF INTRACRANIAL COMPLICATIONS OF CSOM (Context)

INTRACRANIAL COMPLICATIONS OF CSOM
├── EXTRADURAL ABSCESS (Epidural abscess)
├── SUBDURAL EMPYEMA / ABSCESS
├── MENINGITIS (Most common intracranial complication)
├── BRAIN ABSCESS ← (Focus of this answer)
│   ├── Temporal lobe abscess
│   └── Cerebellar abscess
├── LATERAL SINUS THROMBOPHLEBITIS
│   (Sigmoid sinus thrombosis)
├── OTITIC HYDROCEPHALUS
└── CAVERNOUS SINUS THROMBOSIS (rare, usually from rhinogenic)

---

REFERENCES

1. Scott-Brown's Otorhinolaryngology Head and Neck Surgery, 8th Edition — Chapter: Intracranial Complications of Otitis Media
2. Cummings Otolaryngology Head and Neck Surgery, 7th Edition (2021) — Chapter 139: Intracranial Complications of CSOM
3. Stell & Maran's Head and Neck Surgery, 4th Edition — Complications of Suppurative Otitis Media
4. Zakir Hussain's Handbook of ENT Head & Neck Surgery, 2nd Edition — Intracranial Complications
5. Dhingra PL — Diseases of Ear, Nose & Throat, 7th Edition (2018) — Chapter 13: Intracranial Complications of CSOM
6. Hazarika P — Textbook of ENT and Head & Neck Surgery, 3rd Edition — Brain Abscess
7. Harrison's Principles of Internal Medicine, 21st Edition (2022) — Chapter: Intracranial Infections, pp. 4202–4205
8. Brouwer MC, et al. (2014) — Brain Abscess. NEJM 371:447–456
9. IDSA Practice Guidelines for the Management of Brain Abscess (2024 Update)
10. Penido NO, et al. (2005) — Otogenic Brain Abscess: A Review of 41 Cases. Otol Neurotol.
11. Recent Advances: Metagenomic sequencing in culture-negative CNS infections — Lancet Infect Dis (2023); Simultaneous ENT-Neurosurgery approach — J Laryngol Otol (2022)

---

Examiner's Note (RGUHS): This topic consistently carries 10–50 marks in RGUHS MS ENT and DLO examinations. Key scoring points include: (1) Latent stage as the most dangerous stage, (2) Proteus mirabilis as the classic organism, (3) LP being contraindicated, (4) DWI-MRI as distinguishing pyogenic abscess from tumour, (5) Simultaneous ENT + Neurosurgical management as modern approach, and (6) Modified Radical Mastoidectomy as the ENT procedure of choice.